Nachrichten zur Supernus Pharmaceuticals Inc. Aktie

Supernus Pharmaceuticals exec sells over $500k in stock By Investing.com

Supernus Pharmaceuticals exec sells over $500k in stock…

Supernus Pharmaceuticals exec sells $436k in stock By Investing.com

Supernus Pharmaceuticals exec sells $436k in stock…

Supernus Pharmaceuticals executive sells over $2.1m in stock By Investing.com

Supernus Pharmaceuticals executive sells over $2.1m in stock…

Supernus Pharmaceuticals executive trades company stock By Investing.com

Supernus Pharmaceuticals executive trades company stock…

Supernus Pharmaceuticals, Inc. (SUPN) Q4 2023 Earnings Call Transcript

…

Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent

ROCKVILLE, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on…

Top 3 Canadian Biotech Stocks

Canadas biotech sector is home to innovative companies pursuing cutting-edge therapies and medical technologies.Looking ahead into 2024, some market participants…

Terns Pharmaceuticals: Anlagevotum bestätigt

Toronto (www.aktiencheck.de) - Rating-Update: BMO Capital Markets bewertet die Aktie von Terns Pharmaceuticals Inc. (ISIN: US8808811074, WKN: A2QNWR, Ticker-Symbol: 430, NASDAQ-Symbol:…

Supernus Pharmaceuticals, Inc. (SUPN) Q3 2023 Earnings Call Transcript

…

Supernus Announces Third Quarter 2023 Financial Results

ROCKVILLE, Md., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused…

Supernus Pharmaceuticals (SUPN) Reports Q3 Loss, Tops Revenue Estimates

Supernus (SUPN) delivered earnings and revenue surprises of -323.08% and 8.74%, respectively, for the quarter ended September 2023. Do the…

Supernus to Participate in the Jefferies London Healthcare Conference

ROCKVILLE, Md., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on…

Supernus Pharmaceuticals to Announce Third Quarter 2023 Financial Results and Host Conference Call on November 8, 2023

ROCKVILLE, Md., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on…

Jay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree® Journey

ROCKVILLE, Md., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Television personality and sports reporter Jay Glazer is opening up…

Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device

ROCKVILLE, Md., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on…

Supernus Pharmaceuticals Announces Webcast of R&D Day to be Held on October 18, 2023 in New York City

ROCKVILLE, Md., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on…

Supernus Announces New Qelbree® Data Showing Improvement in ADHD Symptoms

ROCKVILLE, Md., Sept. 09, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on…

Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 17

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K/A SUPERNUS PHARMACEUTICALS For: Aug 08

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Compared to Estimates, Supernus (SUPN) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Supernus (SUPN) give a sense of how the business performed in the quarter…

Supernus Pharmaceuticals (SUPN) Reports Q2 Loss, Misses Revenue Estimates

Supernus (SUPN) delivered earnings and revenue surprises of -108.70% and 6.64%, respectively, for the quarter ended June 2023. Do the…

Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 08

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Supernus Announces Second Quarter 2023 Financial Results

ROCKVILLE, Md., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on…

Supernus Pharmaceuticals to Announce Second Quarter 2023 Financial Results and Host Conference Call on August 8, 2023

ROCKVILLE, Md., July 24, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on…

Form 8-K SUPERNUS PHARMACEUTICALS For: Jul 24

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Supernus settles patent litigation with Apotex over Oxtellar XR

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Supernus Pharmaceuticals, Apotex Agree to Settle Patent Litigation

Supernus Pharmaceuticals, Apotex Agree to Settle Patent Litigation...…

Form 8-K SUPERNUS PHARMACEUTICALS For: Jun 21

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K SUPERNUS PHARMACEUTICALS For: Jun 16

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Supernus to Participate in the Jefferies Healthcare Conference

ROCKVILLE, Md., May 31, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on…

Supernus (SUPN) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for Supernus (SUPN) give insight into how the company performed in the quarter ended March 2023, but…

Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Beat Estimates

Supernus (SUPN) delivered earnings and revenue surprises of 141.67% and 8.99%, respectively, for the quarter ended March 2023. Do the…

Supernus Announces First Quarter 2023 Financial Results

ROCKVILLE, Md., May 09, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused…

Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023

ROCKVILLE, Md., April 25, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on…

Supernus Pharmaceuticals pays out $402M senior convertible notes

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K SUPERNUS PHARMACEUTICALS For: Mar 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Supernus Announces Repayment of Convertible Notes

ROCKVILLE, Md., April 03, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on…

Insiderhandel: Sr VP, Quality, GMP Oper. & IT verkauft Aktien von Supernus Pharmaceuticals im Wert von 172.023$

Mottola, Frank - Vorstand - Tag der Transaktion: 2023-03-14...…

Supernus to Participate in Two Upcoming Investor Conferences

ROCKVILLE, Md., March 08, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on…

Supernus Pharmaceuticals (SUPN) Q4 Earnings and Revenues Lag Estimates

Supernus (SUPN) delivered earnings and revenue surprises of -41.10% and 8.15%, respectively, for the quarter ended December 2022. Do the…

Form 8-K SUPERNUS PHARMACEUTICALS For: Feb 28

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Supernus Announces Fourth Quarter and Full Year 2022 Financial Results

1Includes net product sales reported by Adamas Pharmaceuticals prior to the acquisition of Adamas by Supernus Pharmaceuticals in November 2021....…

Supernus secures $150M line of credit from UBS Bank USA

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 28, 2023

ROCKVILLE, Md., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on…

dpa-AFX ProFeed